TrialOncotarget2016

Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation.

Angélica Cuapio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.